Clonal homozygous deletion involving the region 9p21.3, which harbours the tumour suppressors cyclin-dependent kinase inhibitor 2A and B (CDKN2A/B) and methylthioadenosine phosphorylase (MTAP), was found in seven patients (32%). The gene discussed is CDKN2A; the disease is neoplasm.